- Home
- KFFB vs BOLT Comparison
KFFB vs BOLT Comparison
Compare KFFB & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KFFB
- BOLT
- Stock Information
- Founded
- KFFB 2005
- BOLT 2015
- Country
- KFFB United States
- BOLT United States
- Employees
- KFFB N/A
- BOLT N/A
- Industry
- KFFB Savings Institutions
- BOLT Biotechnology: Pharmaceutical Preparations
- Sector
- KFFB Finance
- BOLT Health Care
- Exchange
- KFFB Nasdaq
- BOLT Nasdaq
- Market Cap
- KFFB 21.0M
- BOLT 16.8M
- IPO Year
- KFFB 2005
- BOLT 2021
- Fundamental
- Price
- KFFB $2.90
- BOLT $5.69
- Analyst Decision
- KFFB
- BOLT Buy
- Analyst Count
- KFFB 0
- BOLT 3
- Target Price
- KFFB N/A
- BOLT $50.00
- AVG Volume (30 Days)
- KFFB 6.8K
- BOLT 23.5K
- Earning Date
- KFFB 05-12-2025
- BOLT 08-12-2025
- Dividend Yield
- KFFB N/A
- BOLT N/A
- EPS Growth
- KFFB N/A
- BOLT N/A
- EPS
- KFFB N/A
- BOLT N/A
- Revenue
- KFFB $8,308,000.00
- BOLT $3,638,000.00
- Revenue This Year
- KFFB N/A
- BOLT N/A
- Revenue Next Year
- KFFB N/A
- BOLT $24.14
- P/E Ratio
- KFFB N/A
- BOLT N/A
- Revenue Growth
- KFFB 13.79
- BOLT N/A
- 52 Week Low
- KFFB $1.96
- BOLT $5.20
- 52 Week High
- KFFB $3.62
- BOLT $15.60
- Technical
- Relative Strength Index (RSI)
- KFFB 56.78
- BOLT 42.69
- Support Level
- KFFB $2.61
- BOLT $5.36
- Resistance Level
- KFFB $2.78
- BOLT $6.07
- Average True Range (ATR)
- KFFB 0.16
- BOLT 0.44
- MACD
- KFFB 0.01
- BOLT -0.01
- Stochastic Oscillator
- KFFB 50.67
- BOLT 25.58
About KFFB Kentucky First Federal Bancorp
Kentucky First Federal Bancorp is a holding company. The company through its subsidiaries is engaged mainly in the business of accepting deposits from the general public and using such funds to originate loans secured by first mortgages on owner-occupied, residential real estate and other loans secured by real estate. Its primary products and services include Residential mortgage loans, Multi-family loans, Construction loans and types of deposits, etc. The company mainly operates in Perry, Franklin, Boyle and Garrard and surrounding counties in Kentucky, US.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.